参考文献/References:
[1] VIRAVAIDYA K,SIN A,SHULER M L.Development of a microscale cell culture analog to probe naphthalene toxicity[J].Biotechnol Prog,2004,20(1):316-323.
[2] VIRAVAIDYA K,SHULER M L.Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies[J].Biotechnol Prog,2004,20(2):590-597.
[3] HUH D,MATTHEWS B D,MAMMOTO A,MONTOYA-ZAVALA M,HSIN H Y,INGBER D E.Reconstituting organ-level lung functions on a chip[J].Science,2010,328(5986):1662-1668.
[4] BHATIA S N,INGBER D.Microfluidic organs-on-chips[J].Nat Biotechnol,2014,32(8):760-772.
[5] SKARDAL A,SHUPE T,ATALA A.Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling[J].Drug Discov Today,2016,21(9):1399-1411.
[6] NAWROTH J C,BARRILE R,CONEGLIANO D,VAN RIET S,HIEMSTRA P S,VILLENAVE R.Stem cell-based lung-on-chips:the best of both worlds?[J].Adv Drug Deliv Rev,2019,140:12-32.
[7] COCHRANE A,ALBERS H J,PASSIER R,MUMMERY C L,VAN DEN BERG A,ORLOVA V V,et al.Advanced in vitro models of vascular biology:human induced pluripotent stem cells and organ-on-chip technology[J].Adv Drug Deliv Rev,2019,140:68-77.
[8] WANG J,KHODABUKUS A,RAO L,VANDUSEN K,ABUTALEB N,BURSAC N.Engineered skeletal muscles for disease modeling and drug discovery[J].Biomaterials,2019,221:119416.
[9] NANGIA V,JONAS J B,GEORGE R,LINGAM V,ELLWEIN L,CICINELLI M V,et al.Prevalence and causes of blindness and vision impairment:magnitude,temporal trends and projections in South and Central Asia[J].Br J Ophthalmol,2019,103(7):871-877.
[10] BOURNE R A,FLAXMAN S R,BRAITHWAITE T,CICINELLI M V,DAS A,JONAS J B,et al.Magnitude,temporal trends,and projections of the global prevalence of blindness and distance and near vision impairment:a systematic review and meta-analysis[J].Lancet Glob Heal,2017,5(9):e888-e897.
[11] PASCOLINI D,MARIOTTI S P.Global estimates of visual impairment:2010[J].Br J Ophthalmol,2012,96(5):614-618.
[12] ZHANG J,TUO J,WANG Z,ZHU A,MACHALI N ' SKA A,LONG Q.Pathogenesis of common ocular diseases[J].J Ophthalmol,2015,2015:734527.
[13] BENNET D,ESTLACK Z,REID T,KIM J.A microengineered human corneal epithelium-on-a-chip for eye drops mass transport evaluation[J].Lab Chip,2018,18(11):1539-1551.
[14] SEO J,BYUN W Y,ALISAFAEI F,GEORGESCU A,YI Y S,MASSARO-GIORDANO M,et al.Multiscale reverse engineering of the human ocular surface[J].Nat Med,2019,25(8):1310-1318.
[15] ABDALKADER R,KAMEI K I.Multi-corneal barrier-on-a-chip to recapitulate eye blinking shear stress forces[J].Lab Chip,2020,20(8):1410-1417.
[16] 弥胜利,赵港南,杨星.一种功能性微流控角膜接触镜及其制备方法:CN109288619A[P].2019-02-01.
MI S L,ZHAO G N,YANG X.A functional microfluidic contact lens and its preparation method:CN109288619A[P].2019-02-01.
[17] CHEN L J,ITO S,KAI H,NAGAMINE K,NAGAI N,NISHIZAWA M,et al.Microfluidic co-cultures of retinal pigment epithelial cells and vascular endothelial cells to investigate choroidal angiogenesis[J].Sci Rep,2017,7(1):3538.
[18] YESTE J,GARCA-RAMREZ M,ILLA X,GUIMER A,HERNNDEZ C,SIM R,et al.A compartmentalized microfluidic chip with crisscross microgrooves and electrophysiological electrodes for modeling the blood-retinal barrier[J].Lab Chip,2017,17(1):95-105.
[19] SU P J,LIU Z,ZHANG K,HAN X,SAITO Y,XIA X,et al.Retinal synaptic regeneration via microfluidic guiding channels[J].Sci Rep,2015,5:13591.
[20] CHUNG M,LEE S,LEE B J,SON K,JEON N L,KIM J H.Wet-AMD on a chip:modeling outer blood-retinal barrier in vitro[J].Adv Healthc Mater,2018,7(2):201700028.
相似文献/References:
[1]周希彬 黄一飞.医用牛心包在眼科的应用进展[J].眼科新进展,2013,33(1):000.
[2]吴梦竹 樊莹.转甲状腺素蛋白与眼科疾病的研究进展[J].眼科新进展,2013,33(10):000.
[3]周姝,夏文涛,刘瑞珏,等. 微视野检查评定视觉功能的临床应用研究进展[J].眼科新进展,2015,35(3):293.[doi:10.13389/j.cnki.rao.2015.0079]
ZHOU Shu,XIA Wen-Tao,LIU Rui-Jue,et al. Applications and advances in visual function measured by microperimetry[J].Recent Advances in Ophthalmology,2015,35(10):293.[doi:10.13389/j.cnki.rao.2015.0079]
[4]徐柒华,廖洪斐.3D打印及其在眼科中的应用前景[J].眼科新进展,2016,36(3):295.[doi:10.13389/j.cnki.rao.2016.0080]
XU Qi-Hua,LIAO Hong-Fei.3D printing technology and its potential application in ophthalmology[J].Recent Advances in Ophthalmology,2016,36(10):295.[doi:10.13389/j.cnki.rao.2016.0080]
[5]向菁,康丽华,管怀进.LncRNA在眼科疾病发生发展中的作用机制研究进展[J].眼科新进展,2017,37(6):579.[doi:10.13389/j.cnki.rao.2017.0147]
XIANG Jing,KANG Li-Hua,GUAN Huai-Jin.Research progress on mechanism of lncRNA in ophthalmology disease[J].Recent Advances in Ophthalmology,2017,37(10):579.[doi:10.13389/j.cnki.rao.2017.0147]
[6]纪艳丽,彭广华.单细胞转录组测序在眼科研究领域中的应用[J].眼科新进展,2018,38(1):084.[doi:10.13389/j.cnki.rao.2018.0019]
JI Yan-Li,PENG Guang-Hua.Application of single-cell RNA-sequencing in ophthalmology[J].Recent Advances in Ophthalmology,2018,38(10):084.[doi:10.13389/j.cnki.rao.2018.0019]
[7]吴秋欣,王慧,刘冬梅,等.表没食子儿茶素没食子酸酯(EGCG)抗氧化作用在眼科研究中的应用[J].眼科新进展,2019,39(3):287.[doi:10.13389/j.cnki.rao.2019.0065]
WU Qiu-Xin,WANG Hui,LIU Dong-Mei,et al.Research advance of the mechanism of epigallocatechingallate against oxidative damage in ophthalmology[J].Recent Advances in Ophthalmology,2019,39(10):287.[doi:10.13389/j.cnki.rao.2019.0065]
[8]张国明,田娅.阿柏西普在眼科疾病治疗中的应用[J].眼科新进展,2020,40(1):001.[doi:10.13389/j.cnki.rao.2020.0001]
ZHANG Guoming,TIAN Ya.Advances in application of Aflibercept for treatment of ocular diseases[J].Recent Advances in Ophthalmology,2020,40(10):001.[doi:10.13389/j.cnki.rao.2020.0001]
[9]丰婷,汪沅,聂欢,等.新型冠状病毒肺炎疫情下眼科门诊疾病谱分析及防疫处理对策[J].眼科新进展,2020,40(3):275.[doi:10.13389/j.cnki.rao.2020.0065]
FENG Ting,WANG Yuan,NIE Huan,et al.Analysis and epidemic treatment measures of disease spectrum in ophthalmology clinic during novel coronavirus pneumonia (COVID-19) outbreaks[J].Recent Advances in Ophthalmology,2020,40(10):275.[doi:10.13389/j.cnki.rao.2020.0065]
[10]樊倩,王雁,段学欣,等.智能生物传感器在眼科学领域的应用研究进展[J].眼科新进展,2021,41(5):484.[doi:10.13389/j.cnki.rao.2021.0101]
FAN Qian,WANG Yan,DUAN Xuexin,et al.Advances of intelligent biosensor in ophthalmology[J].Recent Advances in Ophthalmology,2021,41(10):484.[doi:10.13389/j.cnki.rao.2021.0101]